COVID-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated COVID-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated
Covid-19: Vaccine Rivalry? Comparisons Between Moderna, Pfizer Doses Can Get Heated Are you Team Moderna or Team Pfizer? A good-natured rivalry has been brewing between those receiving the Moderna COVID-19 vaccine versus the Pfizer vaccine as more doses have been made available to the majority of the public. Since Americans began receiving their initial doses of the two-shot Moderna and Pfizer vaccines, photos of vaccination cards and celebratory videos of successful shots have flooded social media, with some on both sides taking playful jabs at the other in the process. Related story - COVID:19: COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Va…
COVID-19: Second-Dose Skipping Sparks Concern Among Medical Experts COVID-19: Second-Dose Skipping Sparks Concern Among Medical Experts
Covid-19: Second-Dose Skipping Sparks Concern Among Medical Experts Though millions of COVID-19 vaccines are being administered daily in the United States, some medical experts are now concerned about some eager Americans going to get their first dose and then skipping out on the second out of complacency. Some are citing side effects that come with the second dose of the two-shot Moderna and Pfizer vaccines, which has increased “vaccine-hesitancy” and has some not heading back to their healthcare provider to complete the vaccination process. Others have simply missed appointments or opted against going back to receive a second dose. However, health of…
COVID-19: Pfizer Seeks FDA Approval To Give Vaccines To Kids In New Age Group COVID-19: Pfizer Seeks FDA Approval To Give Vaccines To Kids In New Age Group
Covid-19: Pfizer Seeks FDA Approval To Give Vaccines To Kids In New Age Group Pfizer is seeking federal approval to expand the use of its COVID-19 vaccine in adolescents between the ages of 12 and 15. The company announced that it is asking the Food and Drug Administration to amend its emergency use authorization, which was granted for people ages 16 and up late last year. Now, Pfizer is looking to expand its usage to adolescents as they work to get students back to full in-person learning for the fall semester. Clinical trials of the Pfizer/BioNTech’s COVID-19 vaccine have shown that it has a 100 percent efficacy in adolescents and is well-tolerated in minors betw…
COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients
Covid-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients Those who have taken the Moderna COVID-19 vaccine are reporting more side effects than those who got a dose from Pfizer, according to a new study. Using data from more than three million vaccine recipients collected from the Centers for Disease Control and Prevention (CDC), it was determined that nearly 70 percent of those studied reported minor side effects such as fatigue or chills. Of those reporting side effects, the researchers found that more participants impacted had received the Moderna vaccine compared to the Pfizer vaccine. According to the study, 73 percent of those who got the…
COVID-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective COVID-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective
Covid-19: New Research Reveals Minimum Amount Of Time Moderna Vaccine Remains Effective The Moderna COVID-19 vaccine could provide protection against the virus for a minimum of a half a year, according to a new report published this week. A report in the New England Journal of Medicine was published this week advising that the Moderna vaccine, much like its counterpart from Pfizer, will remain effective against COVID-19 for at least six months once both doses are administered.  The latest report comes after dozens of tests of those who received the shot during the study. With this research, using three separate tests that look for antibodies, the scientists found that pr…
COVID-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says COVID-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says
Covid-19: Vaccinated Americans Get Green Light To Travel, Should Take These Measures, CDC Says Fully vaccinated Americans can resume domestic and overseas travel as long as they wear masks in public, and follow two other measures, according to brand-new guidance from the Centers for Disease Control & Prevention (CDC). They also don't need to be tested for COVID-19 before or after domestic travel and don't have to self-quarantine on return, provided they follow public health measures. The CDC released the guidance on Friday, April 2.  In addition to wearing a mask, fully vaccinated travelers should also: Stay 6 feet from others and avoid crowds Wash your hands often or use…
COVID-19: All Adults 16+ To Be Eligible For Vaccine In CT COVID-19: All Adults 16+ To Be Eligible For Vaccine In CT
Covid-19: All Adults 16+ To Be Eligible For Vaccine In CT A new age group in Connecticut will be eligible to receive the COVID-19 vaccine as of Thursday morning. Gov. Ned Lamont said that Connecticut remains on track to expand COVID-19 vaccine eligibility to all adults over the age of 16 beginning on Thursday, April 1. Additionally, more than 100 additional pharmacies across Connecticut will be added to the state’s vaccination program. Originally, the final group - those between 16 and 44, were to become eligible for the vaccine as of Monday, April 5, but due to the state’s steady rollout of its vaccination program, they accelerated the plan. To…
COVID-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free COVID-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free
Covid-19: Got Your Vaccine? Here's What This Popular Food Chain Will Give You For Free One of the country’s most popular food chains is offering a sweet incentive to encourage Americans to go out and get their COVID-19 vaccination. Krispy Kreme is sweetening the deal for anyone on the fence about getting the vaccine by offering a free daily doughnut at each of their U.S. locations through the end of 2021. No purchase is required to pick up the free treat, one just has to provide proof that they’ve been vaccinated. According to Krispy Kreme, those qualified for the free doughnut include anyone who has received one of the two shots of the Moderna or Pfizer COVID-19 vaccine, o…
COVID-19: Moderna Begins Vaccine Trials For Children, Babies COVID-19: Moderna Begins Vaccine Trials For Children, Babies
Covid-19: Moderna Begins Vaccine Trials For Children, Babies Moderna is moving forward with its latest COVID-19 vaccine trial, testing it in children six months to less than 12 years old as the company reviews the effectiveness and safety of the shot in younger Americans. As part of the study, researchers will be giving two injections 28 days apart of either the Moderna vaccine or a placebo, to the children being tested. The current Moderna vaccine has only been authorized for use in those 18 and older. Kids who get the vaccine will receive one of three possible doses, from 25 micrograms up to 100 micrograms – the same dose that received an emergen…
COVID-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated COVID-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated
Covid-19: CDC Unveils Highly-Anticipated Guidelines For Those Who Are Fully Vaccinated The Centers for Disease Control & Prevention (CDC) has just issued its first guidance for fully vaccinated people during the COVID-19 pandemic. Those who currently count as fully vaccinated are those who have gotten two separate shots of the Pfizer and Moderna vaccines with the second shot coming at least two weeks ago. The rollout for the single-dose Johnson & Johnson vaccine started last week. According to the CDC guidance released late Monday morning, March 8, fully vaccinated people should still: Maintain physical distance in public and wear a well-fitted mask Avoid large- and…
COVID-19: Here's How Many Doses Of New Johnson & Johnson Vaccine CT Will Get, Lamont Announces COVID-19: Here's How Many Doses Of New Johnson & Johnson Vaccine CT Will Get, Lamont Announces
Covid-19: Here's How Many Doses Of New Johnson & Johnson Vaccine CT Will Get, Lamont Announces Tens of thousands of the Johnson & Johnson COVID-19 vaccine have been earmarked for Connecticut, provided it gains federal approval for emergency use by an oversight committee, possibly as soon as this weekend. This week, the Food and Drug administration staff endorsed the new vaccine, which would only require one dose and is easier to store than the current Pfizer and Moderna vaccines. Earlier story - COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use If approved by the FDA’s Vaccines and Related Biological Products Advisory Committee on F…
COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use COVID-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use
Covid-19: One-Dose, Easy-To-Store New Vaccine Gets FDA Approval, Nears OK For Emergency Use The Food and Drug Administration's staff has endorsed Johnson & Johnson’s COVID-19 vaccine for emergency use, paving the way for the one-dose shot to receive its final approval for emergency use in America by a final committee. This week, the FDA announced it supported the approval of the vaccine, which is easier to store and would represent a third vaccination option for those looking to get inoculated as the country combats the virus. The FDA’s Vaccines and Related Biological Products Advisory Committee is expected to meet on Friday, Feb. 26 to determine whether the new vaccine is via…